Keyphrases
Acne Treatment
13%
Advanced Basal Cell Carcinoma
71%
Advanced or Metastatic
14%
Adverse Event Rates
16%
Adverse Events
44%
Alopecia Areata
13%
Antipruritic
13%
Atopic Dermatitis
20%
Azelaic Acid
27%
Basal Cell Carcinoma
59%
Clinical Outcomes
15%
Clinical Practice
27%
Clinical Trials
59%
Consensus Statement
27%
Core Domain Set
27%
Cutaneous Malignancy
27%
Dermatologic Surgery
29%
Expanded Access
22%
Genetic Pathways
13%
Hedgehog Inhibitor
43%
Hedgehog Signaling
21%
Hematological Cancer
13%
Ichthyosis Linearis Circumflexa
13%
Impact on Care
13%
Melanoma
16%
Membrane Association
13%
Metastatic Basal Cell Carcinoma
26%
Moderate-to-severe Psoriasis
13%
Nalmefene
13%
Nevoid Basal Cell Carcinoma Syndrome
29%
Opiods
13%
Papulopustular Rosacea
27%
Pathway Interaction
13%
Phase II Trial
31%
Plasminogen Activator
27%
Pooled Analysis
16%
Psoriasis
27%
Psoriasis Treatment
16%
Psoriatic Arthritis
27%
Randomized Double-blind
15%
Rosaceae
31%
Skin Cancer
19%
Skin Diseases
16%
Therapy Efficacy
14%
Tolerability
17%
Treatment Options
24%
Treatment Recommendations
13%
Uniform Protocol
13%
Vehicle Control
15%
Vismodegib
79%
Medicine and Dentistry
Acneiform Eruption
27%
Adverse Effect
7%
Adverse Event
33%
Alopecia Areata
13%
Azelaic Acid
27%
Basal-Cell Carcinoma
43%
Biopsy Technique
13%
Cancer
30%
Cardiovascular System
13%
Cell Signaling Pathway
14%
Chinese (Language)
13%
Clinical Trial
60%
Clinician
8%
Dermatological Agent
12%
Dermatology
19%
Dermatosis
13%
Diseases
14%
Emerging Treatment
13%
Erythema
6%
Gorlin Syndrome
13%
Hedgehog Signaling
19%
Infection
5%
Itraconazole
6%
Ixekizumab
13%
Malignant Neoplasm
9%
Melanoma
13%
Meta-Analysis
5%
Nevus
11%
Outcome Assessment
10%
Papulopustular
27%
Patient Care
13%
Patient-Reported Outcome
13%
Placebo
11%
Prospective Study
13%
Psoriasis
26%
Psoriasis Vulgaris
15%
Psoriatic Arthritis
13%
Quality of Life
16%
Quality of Life Assessment
5%
Rhinophyma
54%
Scar Formation
13%
Skin Biopsy
13%
Skin Cancer
15%
Skin Surgery
27%
Sun Protection
5%
Sunscreen
5%
Systematic Review
6%
Targeted Therapy
13%
Treatment Response
7%
Vismodegib
7%
Pharmacology, Toxicology and Pharmaceutical Science
Acne
13%
Adverse Event
16%
Alopecia Areata
13%
Antimitotic Agent
13%
Azelaic Acid
27%
Basal Cell Carcinoma
100%
Basal Cell Nevus Syndrome
13%
Chemotherapy
6%
Clinical Trial
34%
Colchicine
10%
Congenital Disorder
13%
Cyclophosphamide
13%
Cytochalasin B
6%
Diseases
9%
Erythema
6%
Genetic Disorder
9%
Hedgehog
51%
Ichthyosis
13%
Itraconazole
6%
Malignant Neoplasm
12%
Melanoma
27%
Nevus
25%
Nocodazole
6%
Plasminogen Activator
27%
Prospective Study
13%
Psoriasis
30%
Psoriatic Arthritis
27%
Rosacea
27%
Scar Formation
13%
Skin Cancer
5%
Skin Disease
13%
Skin Manifestation
13%
Vinblastine
6%
Vismodegib
75%